4-/3-Alanine-oxytocin, an analog of oxytocin containing a /3-alanine residue in place of the glutamine residue in the 4 position in the hormone, has been synthesized and tested for various pharmacological activities in comparison with 4-glycine-oxytocin. Both of these analogs lack the carboxamide-containing side T A he synthesis of oxytocin (du Vigneaud et a/., 1953, 1954), the principal oxytocic and milk-ejecting hormone of the posterior pituitary gland, has provided a means of studying the relationship of chemical structure to biological activity in this octapeptide hormone, the structure of which is shown in Figure 1.Efforts to elucidate this relationship in this and other laboratories during the past decade have centered on the total synthesis of numerous analogs of the hormone, incorporating various modifications of its structure, and the comparison of the pharmacological properties of these synthetic analogs with those of oxytocin. Along with some other aspects of the general problem, the studies in our laboratory have been focused particularly on the importance of the presence of the individual chemical functional groups, the specificity of the 20membered disulfide ring, and the relation of the stereostructure of the seven optically active amino acid residues to the pharmacological manifestations of oxytocin.Recently Drabarek (1964) in this laboratory synthesized three analogs of oxytocin in which the tyrosine, isoleucine, and glutamine residues in positions 2, 3, and 4 were replaced, respectively, by a glycine residue. The only one of these compounds that showed pharmacological activity was 4-glycine-oxytocin, which possessed 5.5 units/mg of oxytocic activity, 17 units/mg of